These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32347068)

  • 41. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Fan W; Yang H; Xue H; Sun Y; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
    Dinglin XX; Ma SX; Wang F; Li DL; Liang JZ; Chen XR; Liu Q; Zeng YD; Chen LK
    Clin Lung Cancer; 2017 May; 18(3):e179-e186. PubMed ID: 28185793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.
    de Jong EEC; van Elmpt W; Rizzo S; Colarieti A; Spitaleri G; Leijenaar RTH; Jochems A; Hendriks LEL; Troost EGC; Reymen B; Dingemans AC; Lambin P
    Lung Cancer; 2018 Oct; 124():6-11. PubMed ID: 30268481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classification of Non-Small Cell Lung Cancer Using Significance Analysis of Microarray-Gene Set Reduction Algorithm.
    Zhang L; Wang L; Du B; Wang T; Tian P; Tian S
    Biomed Res Int; 2016; 2016():2491671. PubMed ID: 27446945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.
    Wen Q; Zhan Y; Zheng H; Zang H; Luo J; Zhang Y; Wang W; Feng J; Lu J; Chen L; Fan S
    Diagn Pathol; 2019 Oct; 14(1):108. PubMed ID: 31601252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Machine learning based combination of multi-omics data for subgroup identification in non-small cell lung cancer.
    Khadirnaikar S; Shukla S; Prasanna SRM
    Sci Rep; 2023 Mar; 13(1):4636. PubMed ID: 36944673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
    Warth A
    Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
    Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
    Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-subtype classification model for non-small cell lung cancer based on radiomics: SLS model.
    Liu J; Cui J; Liu F; Yuan Y; Guo F; Zhang G
    Med Phys; 2019 Jul; 46(7):3091-3100. PubMed ID: 31002395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.